NASDAQ:ITCI   Intra-Cellular Therapies Inc.
Estmated Earnings 2-26..

No rising wedges in the yearly chart..

Short interest a bit over 10%..

There is also an inverse H&S pattern but target would put you at top of cup..

Mid Cup is 28.33. Support is often found under mid cup or handle low (HL)

Not a recommendation
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。